Pharmaceuticals : Shots - Health News Pharmaceuticals
Stories About

Pharmaceuticals

AIDS activist group ACT UP organized numerous protests on Wall Street in the 1980s. The group's tactics helped speed the process of finding an effective treatment for AIDS. Tim Clary/AP hide caption

toggle caption
Tim Clary/AP

How To Demand A Medical Breakthrough: Lessons From The AIDS Fight

  • Download
  • <iframe src="https://www.npr.org/player/embed/689924838/692955908" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A team of researchers in Boston has developed an insulin-delivery system that injects the medicine directly into the stomach wall, which is painless. Felice Frankel/MIT hide caption

toggle caption
Felice Frankel/MIT

Avoiding The Ouch: Scientists Are Working On Ways To Swap The Needle For A Pill

  • Download
  • <iframe src="https://www.npr.org/player/embed/692331050/692466463" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Combining some common antidepressants and opioids can undercut the relief of the painkillers. Daniela Jovanovska-Hristovska/Getty Images hide caption

toggle caption
Daniela Jovanovska-Hristovska/Getty Images

Loretta Boesing, of Park Hills, Mo., with her son Wesley, who underwent a liver transplant in 2012. Boesing worried the potency of her son's anti-rejection medicine could have been affected by the extremely hot weather when it was delivered. Alex Smith/KCUR hide caption

toggle caption
Alex Smith/KCUR

Extreme Temperatures May Pose Risks To Some Mail-Order Meds

  • Download
  • <iframe src="https://www.npr.org/player/embed/673806506/682821275" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The "Medicaid Drug Decisions Transparency Act" would require pharmaceutical companies to disclose their payments to pharmacists and others who serve on state Medicaid drug boards — the advisory groups that decide which drugs Medicaid will and won't cover. Gary Waters/Ikon Images/Getty Images hide caption

toggle caption
Gary Waters/Ikon Images/Getty Images

Atorvastatin, the generic form of Lipitor, can reduce the chances of heart attacks and strokes in people at risk. Side effects, such as muscle pain, are uncommon but should be part of the conversation about starting the medicines, a study concludes. Visuals Unlimited/Getty Images/Visuals Unlimited hide caption

toggle caption
Visuals Unlimited/Getty Images/Visuals Unlimited

Before Starting A Statin, Talk It Over With Your Doctor

  • Download
  • <iframe src="https://www.npr.org/player/embed/672990317/673022656" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The Food and Drug Administration has seen a sharp increase in applications for drug to treat rare diseases. An oversight report found problems with how agency is handling them. Al Drago/CQ Roll Call/Getty Images hide caption

toggle caption
Al Drago/CQ Roll Call/Getty Images

Purdue Pharma, maker of the opioid OxyContin, has a subsidiary that won a patent for a treatment for opioid addiction. Bloomberg via Getty Images hide caption

toggle caption
Bloomberg via Getty Images

Health insurers who offer Medicare Advantage plans have permission to soon require patients to try less expensive alternatives to some before receiving pricier drugs. Witthaya Prasongsin/Getty Images hide caption

toggle caption
Witthaya Prasongsin/Getty Images

Massachusetts wanted to negotiate prices and stop the use of some of the most expensive drugs in its Medicaid program. The federal government said no. Paul Marotta/Getty Images hide caption

toggle caption
Paul Marotta/Getty Images

Intermountain Healthcare, whose Intermountain Medical Center Patient Tower in Murray, Utah, is seen here, is a leader in the generic drug company being launched by hospitals. Courtesy of Intermountain Healthcare hide caption

toggle caption
Courtesy of Intermountain Healthcare

Texas officials are requiring that people who comment at Medicaid meetings on pharmaceuticals disclose more details about their ties to industry. George Rose/Getty Images hide caption

toggle caption
George Rose/Getty Images

Republican Gov. Doug Ducey speaks about a variety of issues during an interview in his office at the Arizona Capitol in May 2018, in Phoenix. Ross D. Franklin/AP hide caption

toggle caption
Ross D. Franklin/AP
Paul Blow for NPR

Investigation: Patients' Drug Options Under Medicaid Heavily Influenced By Drugmakers

  • Download
  • <iframe src="https://www.npr.org/player/embed/629575118/630008647" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Lipitor, a best-seller as a cholesterol treatment, is being tested as a remedy for the flu. Mel Evans/AP hide caption

toggle caption
Mel Evans/AP

Scientists Find New Tricks For Old Drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/625688126/627417605" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

"If my life were to end next week ... I want to feel like I have made a contribution," said Carol Martin, seen here holding her 2018 Boston Marathon medal. Jesse Costa/WBUR hide caption

toggle caption
Jesse Costa/WBUR

Stephanie and Natalie enrolled their older son in sessions at a Brain Balance Achievement Center in the hope that it would help him make friends. Hokyoung Kim for NPR hide caption

toggle caption
Hokyoung Kim for NPR

'Cutting Edge' Program For Children With Autism And ADHD Rests On Razor-Thin Evidence

  • Download
  • <iframe src="https://www.npr.org/player/embed/616805015/621127212" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Food and Drug Commissioner Scott Gottlieb tweeted Tuesday that he is ready to implement a right-to-try law "in a way that achieves Congress' intent to promote access and protect patients." Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images
Stories About

Pharmaceuticals